EXTAVIPRO Trademark

Trademark Overview

On Tuesday, April 18, 2017, a trademark application was filed for EXTAVIPRO with the United States Patent and Trademark Office. The USPTO has given the EXTAVIPRO trademark a serial number of 87414936. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 28, 2020. This trademark is owned by Novartis AG. The EXTAVIPRO trademark is filed in the Medical Instrument Products category with the following description:

Medical syringes; Needles for medical purposes; Injection instruments with needles
extavipro

General Information

Serial Number87414936
Word MarkEXTAVIPRO
Filing DateTuesday, April 18, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 28, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements

Goods and ServicesMedical syringes; Needles for medical purposes; Injection instruments with needles

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 24, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, September 28, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 28, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 19, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, March 3, 2020EXTENSION 5 GRANTED
Thursday, February 20, 2020EXTENSION 5 FILED
Tuesday, March 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 20, 2020TEAS EXTENSION RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2019EXTENSION 4 GRANTED
Wednesday, August 21, 2019EXTENSION 4 FILED
Wednesday, August 21, 2019TEAS EXTENSION RECEIVED
Thursday, February 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 19, 2019EXTENSION 3 GRANTED
Tuesday, February 19, 2019EXTENSION 3 FILED
Tuesday, February 19, 2019TEAS EXTENSION RECEIVED
Thursday, August 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 21, 2018EXTENSION 2 GRANTED
Tuesday, August 21, 2018EXTENSION 2 FILED
Tuesday, August 21, 2018TEAS EXTENSION RECEIVED
Friday, February 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 21, 2018EXTENSION 1 GRANTED
Wednesday, February 21, 2018EXTENSION 1 FILED
Wednesday, February 21, 2018TEAS EXTENSION RECEIVED
Tuesday, August 22, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 11, 2017ASSIGNED TO EXAMINER
Monday, April 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, April 21, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

extavipro medical needles instruments injection purposes syringes